“Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland” (2021) Swiss Medical Weekly, 151(0304), p. w20399. doi:10.4414/smw.2021.20399.